Clarity Capital Partners’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-14,877
Closed -$40.2K 119
2025
Q1
$40.2K Sell
14,877
-3,696
-20% -$13.9K 0.02% 116
2024
Q4
$43.8K Hold
18,573
0.02% 122
2024
Q3
$44K Sell
18,573
-2,995
-14% -$6.59K 0.03% 122
2024
Q2
$42.1K Sell
21,568
-1,098
-5% -$3.73K 0.03% 118
2024
Q1
$146K Sell
22,666
-3,339
-13% -$30.3K 0.1% 114
2023
Q4
$364K Buy
+26,005
New +$411K 0.26% 79

Other funds holding GNLX

Clarity Capital Partners's GNLX Position: Q2 2025 in Review

Clarity Capital Partners sold out of Genelux (GNLX) in Q2 2025, closing a stake of 14,877 shares — an estimated $40.2K sold.

Clarity Capital Partners first reported a position in GNLX in Q4 2023 and held it in 6 quarters. The position peaked at $364K in Q4 2023. 61 funds tracked by Wall St. Rank hold GNLX as of Q2 2025.

  • Clarity Capital Partners reported no remaining Genelux position as of Q2 2025 after selling out during the quarter.
  • Clarity Capital Partners sold 14,877 Genelux shares in Q2 2025, an estimated $40.2K.
  • Clarity Capital Partners first reported a position in Genelux in Q4 2023 and held it in 6 quarters.
  • Clarity Capital Partners's Genelux position peaked at $364K in Q4 2023.
  • 61 funds tracked by Wall St. Rank held Genelux as of Q2 2025.

Based on Clarity Capital Partners's 13F filing for Q2 2025, filed 21 Jul 2025.